Skip to main content

ERRATUM article

Front. Pharmacol., 31 August 2021
Sec. Pharmacology of Anti-Cancer Drugs
Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.758130

Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

This article is an erratum on:

  1. Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

by Al-Odat, O. S., von Suskil, M., Chitren, R. J., Elbezanti, W. O., Srivastava, S. K., Budak-Alpddogan, T., Jonnalagadda, S. C., Aggarwal, B. B., and Pandey, M. K. (2021) Front. Pharmacol. 12:699629. doi: 10.3389/fphar.2021.699629

Due to a production error, several author names were incorrectly written. The names of Omar S. Al-Odat, Robert J. Chitren, Weam O. Elbezanti, Sandeep K. Srivastava, Subash C. Jonnalagadda, and Bharat B. Aggarwal had their initials mistakenly omitted.

The publisher apologizes for this mistake.

Keywords: multiple myeloma, drug resistant, Mcl-1, Bcl-2 homology 3 mimetics, apoptosis

Citation: (2021) Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma. Front. Pharmacol. 12:758130. doi: 10.3389/fphar.2021.758130

Received: 13 August 2021; Accepted: 13 August 2021;
Published: 31 August 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cGhhcm1hY29sb2d5LnByb2R1Y3Rpb24ub2ZmaWNlQGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.